CD8A and cancer: Although we did not compare the antitumor efficiency between polypeptide and eVLP in vivo, eVLP-packaged cancer vaccine really induced neoantigen-specific CD8+ T cells to antitumor.Furthermore, compared to virus-based delivery vectors, lentiviruses can stably integrate into the host genome but carry the risk of insertional mutagenesis.